Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811079 · ClinicalTrials.gov registry record · NA
The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04811079 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 53 participants.
The verdict
NCT04811079, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.
Interventions
- OTHER 419 nm Spectacle Filter
- OTHER 437 nm Spectacle Filter
- OTHER 456 nm Spectacle Filter
- OTHER 476 nm Spectacle Filter
- OTHER 373 nm Spectacle Filter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2022-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04811079
The ClinicalTrials.gov registry entry for NCT04811079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 419 nm Spectacle Filter is the first listed.
NCT04811079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04811079 about?
NCT04811079 is a clinical study titled "The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer". This is a 6-visit, single-center, non-dispensing, randomized, single-masked, 5×5 crossover study. Subjects will participate in 6 scheduled over the duration of approximately 10.5 months.
What is the current status of trial NCT04811079?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-07-14. Estimated completion is 2022-05-16.
What interventions are being tested in trial NCT04811079?
The interventions under investigation include: 419 nm Spectacle Filter (OTHER), 437 nm Spectacle Filter (OTHER), 456 nm Spectacle Filter (OTHER), 476 nm Spectacle Filter (OTHER), 373 nm Spectacle Filter (OTHER).
Who is sponsoring clinical trial NCT04811079?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.